<DOC>
	<DOCNO>NCT00052130</DOCNO>
	<brief_summary>This Phase 3 study patient melanoma spread lymph node ( stage III ) , cancer surgically remove . The purpose study evaluate ability CancerVaxâ„¢ vaccine prevent slow recurrence melanoma .</brief_summary>
	<brief_title>Vaccine Therapy Patients With Stage III Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Must Stage III melanoma Must clinicallydetectable disease surgically remove Can take medication , undergo therapy compromise function immune system ( ie . Some corticosteroid , certain type radiation therapy ) Can HIV Hepatitis A , B , C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2004</verification_date>
</DOC>